Ohio officials are ratcheting up their closely watched battle with pharmacy benefit managers as the state attorney general is seeking nearly $16 million from OptumRx for allegedly failing to pass along discounts for generic drugs that were purchased by a state agency.

In a Feb. 11 letter to the pharmacy benefit manager, Attorney General Dave Yost claims that Optum failed to manage the purchases and “wrongfully increased prices” to the Ohio Bureau of Workers’ Compensation between 2015 and 2018. He also noted that he considers the “overcharges” to be a “matter of considerable public significance,” and that funds sought do not include damages.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy